Mostrar el registro sencillo del ítem
Rational development of a novel hydrogel as a pH-sensitive controlled release system for nifedipine
dc.contributor.author | Avila-Salas F. | |
dc.contributor.author | Rodriguez Nuñez Y.A. | |
dc.contributor.author | Marican A. | |
dc.contributor.author | Castro R.I. | |
dc.contributor.author | Villaseñor J. | |
dc.contributor.author | Santos L.S. | |
dc.contributor.author | Wehinger S. | |
dc.contributor.author | Durán-Lara E.F. | |
dc.date.accessioned | 2020-09-02T22:12:33Z | |
dc.date.available | 2020-09-02T22:12:33Z | |
dc.date.issued | 2018 | |
dc.identifier | 10.3390/polym10070806 | |
dc.identifier.citation | 10, 7, - | |
dc.identifier.issn | 20734360 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/3651 | |
dc.description | This work depicts the rational development (in-silico design, synthesis, characterization and in-vitro evaluation) of polyvinyl alcohol hydrogels (PVAH) cross-linked with maleic acid (MA) and linked to γ-cyclodextrin molecules (γ -CDPVAHMA) as systems for the controlled and sustained release of nifedipine (NFD). Through computational studies, the structural blocks (PVA chain + dicarboxylic acid + γ-CD) of 20 different hydrogels were evaluated to test their interaction energies (ΔE) with NFD. According to the DE obtained, the hydrogel cross-linked with maleic acid was selected. To characterize the intermolecular interactions between NFD and γ-CDPVAHMA, molecular dynamics simulation studies were carried out. Experimentally, three hydrogel formulations with different proportions of γ-CD (2.43%, 3.61% and 4.76%) were synthesized and characterized. Both loading and release of NFD from the hydrogels were evaluated at acid and basic pH. The computational and experimental results show that γ-CDs linked to the hydrogels were able to form 1:1 inclusion complexes with NFD molecules. Finally, γ-CDPVAHMA-3 demonstrated to be the best pH-sensitive release platform for nifedipine. Its effectiveness could significantly reduce the adverse effects caused by the anticipated release of NFD in the stomach of patients. © 2018 by the authors. | |
dc.language.iso | en | |
dc.publisher | MDPI AG | |
dc.subject | Crosslinking | |
dc.subject | Cyclodextrin | |
dc.subject | Drug release | |
dc.subject | Interaction energy | |
dc.subject | Molecular simulation | |
dc.subject | Nifedipine | |
dc.subject | Swelling | |
dc.subject | Thermogravimetric analysis | |
dc.subject | Carboxylic acids | |
dc.subject | Crosslinking | |
dc.subject | Cyclodextrins | |
dc.subject | Drug products | |
dc.subject | Hydrogels | |
dc.subject | Molecular dynamics | |
dc.subject | Molecules | |
dc.subject | pH sensors | |
dc.subject | Pyridine | |
dc.subject | Swelling | |
dc.subject | Synthesis (chemical) | |
dc.subject | Targeted drug delivery | |
dc.subject | Thermogravimetric analysis | |
dc.subject | Computational studies | |
dc.subject | Controlled release systems | |
dc.subject | Drug release | |
dc.subject | Interaction energies | |
dc.subject | Intermolecular interactions | |
dc.subject | Molecular dynamics simulations | |
dc.subject | Molecular simulations | |
dc.subject | Nifedipine | |
dc.subject | Controlled drug delivery | |
dc.title | Rational development of a novel hydrogel as a pH-sensitive controlled release system for nifedipine | |
dc.type | Article |